常用催眠药物研究进展
Progress of Commonly Used Hypnotic Drugs
DOI: 10.12677/JOCR.2015.33015, PDF, HTML, XML,  被引量 下载: 3,182  浏览: 17,703 
作者: 高 婷, 邵开元：北京神剑天军医学科学院，北京；刘亚军, 王 刚：北京市信息技术研究所，北京；胡文祥：北京神剑天军医学科学院，北京；总装备部疾病预防控制中心，北京
关键词: 催眠药；苯二氮?类；非苯二氮?类；双重受体拮抗剂；Hypnotics； Benzodiazepine； Non-Benzodiazepine； Dual Receptor Antagonist
摘要: 本文综述了几类常用催眠药有关研究进展，展望了新型催眠药的探索研究，建议了催眠药物的使用指导原则。
Abstract: The related research progress in several kinds of commonly used hypnotic was reviewed. The two kinds of novel hypnotic and the guidelines using hypnotic drug were suggested.
文章引用：高婷, 刘亚军, 王刚, 邵开元, 胡文祥. 常用催眠药物研究进展[J]. 有机化学研究, 2015, 3(3): 105-114. http://dx.doi.org/10.12677/JOCR.2015.33015

参考文献

[1] 陈新谦 (1973) 新编药物学. 第十版, 人民卫生出版社, 北京, 242.
[2] 周自永 (1987) 新编常用药物手册. 金盾出版社, 北京, 32.
[3] 周晓喜 (2011) 治疗失眠的药物及其研究进展. 海峡药学, 23, 88-90.
[4] 郭宗儒 (2005) 药物化学. 高等教育出版社, 北京, 115-124.
[5] Kaplan, H.I. and Sadoek, B.J. (1992) Psyehiatriedrug treatment. Williams & Wilkins, Baltimore, 25.
[6] Michael Kaplan, E. and Dupont, R.L. (2005) Benzodiazepines and anxiety disorders: A review for the practicing physician. Current Opinion in Psychiatry, 21, 41-50.
[7] 杨庆林 (2013) 精神疾病患者应用苯二氮䓬类药物状况分析. 中国现代药物应用, 7, 106-107.
[8] 姚玲, 曹德鹏 (2012) 住院精神病人苯二氮䓬类药物应用分析. 中国民康医学, 24, 2082-2084.
[9] 陈新谦, 金有豫, 汤光 (2007) 新编药物学. 第十六版, 人民卫生出版社, 北京, 11.
[10] 王泽民 (2003) 失眠症治疗药物现状调查. 现代中西医结合杂志, 8, 1796-1797.
[11] 李华芳, 顾牛范 (2000) 新型非苯二氮䓬类镇静催眠药扎来普隆. 中国新药与临床杂志, 6, 495.
[12] Srinivasan, V., Spence, D.W., Pandi-Perumal, S.R., Trakht, I. and Cardinali, D.P. (2008) Jet lag: Therapeutic use of melatonin and possible application of melatonin analogs. Travel Medicine and Infectious Disease, 6, 17-28.
http://dx.doi.org /10.1016/j.tmaid.2007.12.002
[13] 周俊翔, 吴逢波, 唐尧 (2012) 雷美替胺治疗成人慢性失眠的系统评价. 中国循证医学杂志, 3, 314-319.
[14] 周俊翔, 余文韬, 吴斌, 柳汝明, 唐尧 (2011) 雷美替胺治疗老年人慢性原发性失眠的系统评价. 中国药房, 38, 3593-3596.
[15] Mini, L., Wang-Weigand, S. and Zhang, J. (2008) Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: Post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Clinical Therapeutics, 30, 1316-1323.
http://dx.doi.org /10.1016/S0149-2918(08)80056-2
[16] Uchiyama, M., Hamamura, M., Kuwano, T., Nishiyama, H., Nagata, H. and Uchimura, N. (2011) Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia. Sleep Medicine, 12, 119-126.
http://dx.doi.org /10.1016/j.sleep.2010.08.010
[17] Gooneratne, N.S., Gehrman, P., Curubhagavatula, I., Al-Shehabi, E., Marie, E. and Schwab, R. (2010) Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: A randomized placebo-controlled pilot study. Journal of Clinical Sleep Medicine, 6, 572-580.
[18] Quera Salva, M.A., Vanier, B., Laredo, J., Hartley, S., Chapotot, F., Moulin, C., et al. (2007) Major depressive disorder, sleep EEG and agomelatine: An open-label study. International Journal of Neuropsychopharmacology, 10, 691-696.
[19] Quera-Salva, M.A., Lemoine, P. and Guilleminault, C. (2010) Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients. Human Psychopharmacology, 25, 222-229.
http://dx.doi.org /10.1002/hup.1112
[20] Hale, A., Corral, R.M., Mencacci, C., Ruiz, J.S., Severo, C.A. and Gentil, V. (2010) Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: A randomized, double-blind study. International Clinical Psychopharmacology, 25, 305-314.
[21] Rajaratnam, S.M., Polymeropoulos, M.H., Fisher, D.M., Roth, T., Scott, C., Birznieks, G. and Klerman, E.B. (2009) Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: Two randomised controlled multicentre trials. The Lancet, 373, 482-491.
http://dx.doi.org /10.1016/S0140-6736(08)61812-7
[22] Owen, R.T. (2009) Selective histamine H1 antagonism: A novel approach to insomnia using low-dose doxepin. Drugs of Today, 45, 261-267.
http://dx.doi.org /10.1358/dot.2009.45.4.1358835
[23] Roth, A.J., McCall, W.V. and Liguori, A. (2011) Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. Journal of Sleep Research, 20, 552-558.
http://dx.doi.org /10.1111/j.1365-2869.2011.00928.x
[24] Shen, J., Chung, S.A., Kayumov, L., Moller, H., Hossain, N., Wang, X., et al. (2006) Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Canadian Journal of Psychiatry, 51, 27-34.
[25] Rosenberg, R., Seiden, D.J., Hull, S.G., Erman, M., Schwartz, H., Anderson, C., et al. (2008) APD 125, a selective serotonin 5-HT2A receptor inverse agonist, significantly improves sleep maintenance in primary insomnia. Sleep, 31, 1663-1671.
[26] 王桂芝, 胡海涛, 高健, 赵琦, 张特利 (2009) 镇静催眠药物的研究进展. 中外医疗, 19, 101-103.
[27] Shinomiya, K., Fujimura, K., Kim, Y. and Kamei, C. (2012) Effects of valerian extract on the sleep-wake cycle in sleep-disturbed rats. Acta Medica Okayama, 59, 89-92.
[28] 张劲鹏, 张恩霞 (2010) 缬草镇静催眠作用的实验研究. 内蒙古中医药, 10, 34.
[29] 孙付军, 陈慧慧, 王春芳 (2010) 柏子仁皂苷和柏子仁油改善睡眠作用的研究. 世界中西医结合杂志, 5, 394- 395.
[30] 肖韦华, 刘宗林, 李智欣 (2007) 柏子仁中改善睡眠有效成分的研究. 食品科学, 7, 475-479.
[31] 徐仲航, 金向群 (2011) 植物油提取新工艺得到的五味子提取物对小鼠睡眠影响的实验研究. 中国实验诊断学, 5, 819-821.
[32] 高剑锋, 张洪生 (2010) 五味子对中枢神经系统作用的研究概述. 中国药师, 12, 1813-1816.
[33] 徐丽华, 黄芳, 孙萌, 梁春霞, 吴洁, 余伯阳 (2009) 南北五味子镇静催眠活性部位共有成分的分析. 分析化学, 6, 828-834.
[34] 江海涛, 任源浩, 虞蔚岩 (2008) 灵芝提取物在睡眠改善中的功能性研究. 时珍国医国药, 9, 2231-2232.
[35] Cui, X.Y., Cui, S.Y., Zhang, J., Wang, Z.J., Yu, B., Sheng, Z.F., Zhang, X.Q. and Zhang, Y.H. (2011) Extract of Ganoderma lucidum prolongs sleep time in rats. Journal of Ethnopharmacology, 139, 796-800.
http://dx.doi.org /10.1016/j.jep.2011.12.020
[36] 黄维, 金邦荃, 程光宇, 杨云峰, 冯波, 吴京燕 (2008) 酸枣仁功效成分测定及改善睡眠保健功能的研究. 时珍国医国药, 5, 1173- 1175.
[37] 王丽娟, 张明春, 李彬, 代昆 (2010) 酸枣仁半仿生提取物和醇提取物对睡眠的改善作用. 时珍国医国药, 12, 50.
[38] 孙立梅, 张雷 (2012) 酸枣仁水提取物的镇静催眠试验研究. 吉林农业科技学院学报, 2, 1-3.
[39] 李培育 (2011) 酸枣仁提取物对小鼠镇静催眠作用的研究. 中国民康医学, 21, 2627-2630.
[40] Fang, X.S., Hao, J.F., Zhou, H.Y., Zhu, L.X., Wang, J.H. and Song, F.Q. (2010) Pharmacological studies on the sedative-hypnotic effect of Semen Ziziphi spinosae (Suanzaoren) and Radix et Rhizoma Salviae miltiorrhizae (Danshen) extracts and the synergistic effect of their combinations. Phytomedicine, 17, 75-80.
http://dx.doi.org /10.1016/j.phymed.2009.07.004
[41] 刘正, 郭凌鸿, 徐昕红, 曲卫敏, 黄志力 (2011) 西红花有效成分的神经药理学研究进展. 时珍国医国药, 5, 1202-1204.
[42] 张雄飞, 竹剑平 (2008) 白芍提取物对小鼠改善睡眠的影响. 当代医学, 12, 33-34.
[43] 李文艳, 黄山君, 王瑞 (2012) 中药白芍的药理作用和质量控制研究进展. 药学服务与研究, 2, 118-122.
[44] 贺娟, 冯玛莉, 刘霞, 贾力莉, 武玉鹏, 牛艳艳 (2007) 蛇床子提取物的镇静催眠作用. 山西中医, 5, 61-62.
[45] 仝立国, 宋美卿, 冯玛莉, 贾力莉, 武玉鹏, 牛艳艳 (2011) 谱效关系分析蛇床子镇静催眠的活性物质. 山西中医, 6, 52-53.
[46] de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., et al. (1998) The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America, 95, 322-327.
http://dx.doi.org /10.1073/pnas.95.1.322
[47] Sakurai, T., Amemiya, A., Lshii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., et al. (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G pro-tein-coupled receptor that regulate feeding behavior. Cell, 92, 573-585.
http://dx.doi.org /10.1016/S0092-8674(00)80949-6
[48] Piper, D.C., Upton, N., Smith, M.I. and Hunter, A.J. (2000) The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. European Journal of Neuroscience, 12, 726-730.
http://dx.doi.org /10.1046/j.1460-9568.2000.00919.x
[49] Bennett, T., Bray, D. and Neville, M.W. (2014) Suvorexant, a dual orexin receptor antagonist for the management of insomnia. P & T: A Peer-Reviewed Journal for Formulary Management, 39, 264-266.
[50] Herring, W.J., Snyder, E., Budd, K., Hutzelmann, J., Snavely, D., Liu, K., et al. (2012) Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant. Neurology, 79, 2265-2274.
http://dx.doi.org /10.1212/WNL.0b013e31827688ee
[51] Landolt, H.P. and Wehrle, R. (2009) Antagonism of serotonergic 5-HT2A/2C receptors: Mutual improvement of sleep, cognition and mood? European Journal of Neuroscience, 29, 1795-1809.
http://dx.doi.org /10.1111/j.1460-9568.2009.06718.x
[52] Teegarden, B.R., Al Shamma, H. and Xiong, Y. (2008) 5-HT2A inverse-agonists for the treatment of insomnia. Current Topics in Medicinal Chemistry, 8, 969-976.
http://dx.doi.org /10.2174/156802608784936700
[53] Lewis, V. (2009) Undertreatment of menopausal symptoms and novel options for comprehensive management. Current Medical Research Opinion, 25, 2689-2698.
http://dx.doi.org /10.1185/03007990903240519
[54] Griebel, G., Beeské, S., Jacquet, A., Laufrais, C., Alonso, R., Decobert, M., et al. (2013) Further evidence for the sleep-promoting effects of 5-HT2A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats. Neuropharmacology, 70, 19-26.
http://dx.doi.org /10.1016/j.neuropharm.2012.12.008

为你推荐